Mai Khanfar

Prof. Mai Khanfar

Fauclty of Pharmacy-Jordan University of Science and Technolgoy- Irbid-Jordan
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MTMahmoud Teaima
Mahmoud Teaima
Sandra Moh'd HababehSandra Moh'd Hababeh
Sandra Moh'd Hababeh
MKMai Khanfar
Mai Khanfar
FAFars Al Anazi
Fars Al Anazi
DADoaa Alshora
Doaa Alshora
MEMohamed A El-Nabarawi
Mohamed A El-Nabarawi
Pioglitazone Hydrochloride (PGZ) suffers from poor aqueous solubility. The aim of this research was to design orally disintegrating tablets with self-nanoemulsifying properties (T-SNEDDS) to improve the Pioglitazone solubility and dissolution rate. Three liquid self-nanoemulsifying systems (L-SNEDDS) were formulated and evaluated for transmittance percentage, emulsification time, particle size, Poly dispersity index (PDI), percentage of content, solubility and stability. The optimum L-SNEDDS formula was converted to a solidified self-nanoemulsifying drug delivery system (S-SNEDDS) by adsorption on Syloid (SYL). Powder characterization tests, such as flowability tests, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD) and scanning electron microscopy (SEM), were performed for the selected S-SNEDDS formulation. Orally disintegrating tablets (ODT) were formulated by blending S-SNEDDS with tableting excipients. The ODT tablet batch composed of Prosolv was selected for tablet quality control tests, such as hardness, friability, disintegration time, content uniformity, weight variation, in vitro release, in vivo studies and accelerated stability studies. ODT tablets showed accepted mechanical properties and rapid disintegration time ( 0.05). In vivo pharmacokinetic and pharmacodynamic evaluation of ODTs showed better behavior compared to the raw drug suspension and the commercial tablet (p > 0.05). Orally disintegrating tablets revealed a promising potential to improve Pioglitazone poor aqueous solubility, dissolution profile and bioavailability.

21 March 2021 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
MKMai Khanfar
Mai Khanfar
MAMayyas Al-Remawi
Mayyas Al-Remawi
FAFaisal Al-Akayleh
Faisal Al-Akayleh
SHSuha Hmouze
Suha Hmouze

4 October 2023 in Molecules
Verified
Journal Article
Open access
PDF file
DLDhari K. Luhaibi
Dhari K. Luhaibi
HAHiba Hani Mohammed Ali
Hiba Hani Mohammed Ali
Israa Hamid Al-AniIsraa Hamid Al-Ani
Israa Hamid Al-Ani
NSNaeem Shalan
Naeem Shalan
FAFaisal Al-Akayleh
Faisal Al-Akayleh
MKMai Khanfar
Mai Khanfar
The current work was aimed at the development of a topical drug delivery system for azelaic acid (AzA) for acne treatment. The systems tested for this purpose were deep eutectic systems (DESs) prepared from choline chloride (CC), malonic acid (MA), and PEG 400. Three CC to MA and eight different MA: CC: PEG400 ratios were tested. The physical appearance of the tested formulations ranged from solid and liquid to semisolid. Only those that showed liquid formulations of suitable viscosity were considered for further investigations. A eutectic mixture made from MA: CC: PEG400 1:1:6 (MCP 116) showed the best characteristics in terms of viscosity, contact angle, spreadability, partition coefficient, and in vitro diffusion. Moreover, the MCP116 showed close rheological properties to the commercially available market lead acne treatment product (Skinorin®). In addition, the formula showed synergistic antibacterial activity between the MA moiety of the DES and the AzA. In vitro diffusion studies using polyamide membranes demonstrated superior diffusion of MCP116 over the pure drug and the commercial product. No signs of skin irritation and edema were observed when MCP116 was applied to rabbit skin. Additionally, the MCP116 was found to be, physically and chemically, highly stable at 4, 25, and 40 °C for a one-month stability study.

24 April 2012 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
MKMai Khanfar
Mai Khanfar
MSM. Sheikh Salem
M. Sheikh Salem
RHR. Hawari
R. Hawari
Liquisolid technique is one of the methods used to improve the dissolution rate of the poorly water soluble drugs utilizing non volatile liquids. Enhancement of the release of ezetimibe from different liquisolid formulations. Four liquid vehicles were used to prepare the liquid medications with different drug concentrations. The interaction between the drug and the excipients in liquisolid powders were characterized by DSC, X-ray, FTIR and SEM. Furthermore, the powder characteristics were evaluated by Carr's Index and powder wetting time determinations, respectively. All prepared formulations were compressed at different pressures to end with the same constant porosity and the tablets were evaluated by different tests and compared with conventional formula. No interaction had been detected in all liquisolid formulations as shown in the results of XRD, FTIR, DSC and SEM. In addition to that, all liquisolid compacts had expressed faster dissolution profiles compared with that of conventional formula. The dissolution rate was affected by the drug concentration, solubility of the drug in the liquid vehicle and type of carrier. In addition, the presence of the liquid vehicle has been found to affect the mechanical properties of the liquisolid formulations.

26 January 2017 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
MKMai Khanfar
Mai Khanfar
SASuhair Al-Nimry
Suhair Al-Nimry

19 December 2012 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
MKMai Khanfar
Mai Khanfar
MSM. Sheikh Salem
M. Sheikh Salem
FKFaiza Kaddour
Faiza Kaddour
Context: The aim of this study is to control the dissolution rate of Venlafaxine HCl. Objective: To prepare sustained release tablets of Venlafaxine HCl. Material and methods: Different liquisolid formulations, liquid vehicles, drug concentration in the liquid medication and different ratios of carrier to coating material (R) were prepared. The prepared powders were characterized for possible interactions between drug and excipients using differential scanning calorimetry, X-ray, Fourier transform infrared analysis and scanning electron microscopy. Powder flowability was also evaluated, then they are compressed at different compression forces, and the compressed tablets were evaluated for their mechanical properties and dissolution profile. Results: Release results show that sustained release behavior can be obtained from liquisolid formulation containing Tween 80 as liquid vehicle. Discussion: Many factors affect the retardation effect of Venlafaxine HCl such as the type of liquid vehicle, drug concentration in the liquid medication and R. The mechanism of the in vitro release profiles was found to be mainly controlled by diffusion and polymer relaxation. Conclusion: Sustained release formulation of Venlafaxine HCl was attained using the liquisolid technique.